Leveraging real-world data to advance biomarker discovery and precision oncology Editorial


Authors: Luo, J.; Solit, D. B.
Title: Leveraging real-world data to advance biomarker discovery and precision oncology
Abstract: Precision oncology is predicated on the availability of robust biomarkers deployed at scale at the point of care. Although simple in conception, precision oncology often fails in practice because of the limitations of current diagnostic platforms, the emergence of drug resistance, and an incomplete understanding of cancer pathogenesis and the host immune response. Here, we discuss using real-world data, including exceptional responder analyses, to identify biomarkers of therapy response and strategies for overcoming barriers to the broader adoption of precision oncology paradigms. © 2025 Elsevier Inc.
Keywords: treatment response; note; tumor marker; oncogene; data analysis; point of care testing; dna sequencing; human; personalized cancer therapy; molecular fingerprinting
Journal Title: Cancer Cell
Volume: 43
Issue: 4
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2025-04-14
Start Page: 606
End Page: 610
Language: English
DOI: 10.1016/j.ccell.2025.03.012
PUBMED: 40154486
PROVIDER: scopus
DOI/URL:
Notes: Note -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David Solit
    781 Solit
  2. Jiaqian Luo
    3 Luo